SMI
13.281,67
PKT
+229,50
PKT
+1,76
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.12.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 16.12.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 15.12.22 | Givaudan Hold | Deutsche Bank AG | |
| 15.12.22 | UBS Buy | Goldman Sachs Group Inc. | |
| 14.12.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 14.12.22 | Givaudan Underweight | JP Morgan Chase & Co. | |
| 14.12.22 | Novartis Neutral | UBS AG | |
| 14.12.22 | Roche Neutral | UBS AG | |
| 13.12.22 | Nestlé Neutral | Credit Suisse Group | |
| 13.12.22 | Givaudan Sell | UBS AG | |
| 12.12.22 | Novartis Buy | Jefferies & Company Inc. | |
| 09.12.22 | Novartis Sell | Deutsche Bank AG | |
| 09.12.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 09.12.22 | UBS Neutral | Credit Suisse Group | |
| 08.12.22 | Novartis Market-Perform | Bernstein Research | |
| 08.12.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.22 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
| 08.12.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 08.12.22 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 07.12.22 | Novartis Sell | Deutsche Bank AG | |
| 06.12.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 06.12.22 | Novartis Neutral | UBS AG | |
| 05.12.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 05.12.22 | Nestlé Market-Perform | Bernstein Research | |
| 05.12.22 | UBS Buy | Jefferies & Company Inc. | |
| 02.12.22 | Swiss Re Sell | UBS AG | |
| 02.12.22 | Zurich Insurance Buy | UBS AG | |
| 02.12.22 | Nestlé Hold | Deutsche Bank AG | |
| 02.12.22 | Roche Hold | Deutsche Bank AG | |
| 01.12.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 01.12.22 | Nestlé Hold | Deutsche Bank AG | |
| 01.12.22 | UBS Neutral | JP Morgan Chase & Co. | |
| 01.12.22 | Givaudan Underweight | JP Morgan Chase & Co. | |
| 30.11.22 | Nestlé Neutral | Credit Suisse Group | |
| 30.11.22 | Nestlé Buy | Goldman Sachs Group Inc. | |
| 30.11.22 | Nestlé Sector Perform | RBC Capital Markets | |
| 29.11.22 | Nestlé Buy | UBS AG | |
| 29.11.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 29.11.22 | Nestlé Buy | Goldman Sachs Group Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.